3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
3
Overweight
2
Obesity
2
Colorectal Neoplasms
2
Weight Loss
1
Ovarian Neoplasms
1
Motor Activity
1
Metastatic Pancreatic Adenocarcinoma
1
Lung Neoplasms
1
Leukemia
1
Intermittent Fasting
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Feeding Behavior
1
Fasting
1
Depressive Disorder
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
venetoclax
21
Cyclophosphamide
14
Cytarabine
12
Azacitidine
8
fludarabine
7
Dexamethasone
5
Daunorubicin
5
ruxolitinib
4
revumenib
4
Trimethoprim, Sulfamethoxazole Drug Combination
4
quizartinib
3
pirtobrutinib
3
gamma-Globulins
3
fludarabine phosphate
3
blinatumomab
3
Tacrolimus
3
Rituximab
3
Palliative Care
3
Inotuzumab Ozogamicin
3
Granulocyte Colony-Stimulating Factor
3
Decitabine
3
Ciprofloxacin
3
Blood Specimen Collection
3
zanubrutinib
2
ponatinib
2
pembrolizumab
2
ibrutinib
2
aldesleukin
2
acalabrutinib
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Leukemia
×
Counseling
×
Clear all
NCT05270096
2026-01-09
iLTB
Princess Maxima Center for Pediatric Oncology
Recruiting
600 enrolled